Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
Lancet (London, England)|October 11, 2014
Livebirth after uterus transplantationMats Brännström, Liza Johannesson, Hans Bokström, et al.European Journal of Haematology|June 1, 2011
Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusionsHerman Nilsson-Ehle, Gunnar Birgegård, Jan Samuelsson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasmsMagnus Björkholm, Asa R Derolf, Malin Hultcrantz, et al.Nature Medicine|May 24, 2005
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemiaAnders Castor, Lars Nilsson, Ingbritt Astrand-Grundström, et al.Neurology. Genetics|August 31, 2017
Ataxia-pancytopenia syndrome with <i>SAMD9L</i> mutationsSorina Gorcenco, Jonna Komulainen-Ebrahim, Karin Nordborg, et al.Clinical Lymphoma, Myeloma & Leukemia|March 11, 2026
Spleen Volume Reduction and Transfusion Independence With Momelotinib Versus Ruxolitinib and Associated Overall Survival With Momelotinib in JAK Inhibitor-Naive Patients With Myelofibrosis and Anemia: Subgroup Analyses of SIMPLIFY-1Francesca Palandri, Nicolaas P M Schaap, Jerome Rey, et al.Blood|July 10, 2007
The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromesLars Nilsson, Patrik Edén, Eleonor Olsson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndromeMichael Grövdal, Rasheed Khan, Anni Aggerholm, et al.Haematologica|July 2, 2011
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalitiesLars Möllgård, Leonie Saft, Marianne Bach Treppendahl, et al.Biorxiv : the Preprint Server for Biology|February 6, 2026
Structural heterogeneity in mRNA-LNP subpopulations revealed by AF4-SAXS: implications for cargo loading and cell transfectionAdrian Sanchez-Fernandez, Keira A Donnelly, Hans Bolinsson, et al.Pageof 15